Published in Am J Pathol on January 01, 1988
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med (1994) 3.94
The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigment Cell Res (2005) 2.71
Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell (2001) 2.48
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J Cell Biol (2003) 2.12
Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol (1993) 1.51
A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol (2005) 1.27
Premelanosome amyloid-like fibrils are composed of only golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes. J Biol Chem (2007) 1.17
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation. Mol Biol Cell (2005) 1.05
Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage. Br J Cancer (1997) 1.00
Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol (2014) 0.98
PMEL: a pigment cell-specific model for functional amyloid formation. Pigment Cell Melanoma Res (2013) 0.97
Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer (2003) 0.97
The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding. FASEB J (2009) 0.97
Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization. J Immunol Methods (1998) 0.95
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci (2014) 0.85
Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res (1993) 0.79
pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br J Cancer (1996) 0.79
Catechol-O-methyltransferase in vitiligo. Arch Dermatol Res (1994) 0.78
The Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation. J Biol Chem (2015) 0.76
Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody. J Clin Invest (1988) 0.75
Two cases of melasma with unusual histopathologic findings. J Korean Med Sci (2006) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Production of monoclonal antibodies: strategy and tactics. J Immunol Methods (1980) 9.28
Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D. J Biol Chem (1981) 2.47
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol (1986) 2.26
Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol (1983) 1.95
A method for the efficient blotting of strongly basic proteins from sodium dodecyl sulfate-polyacrylamide gels to nitrocellulose. Anal Biochem (1985) 1.59
Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer (1981) 1.55
A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site. Application to hybridomas specific for the beta 2-subunit of Escherichia coli tryptophan synthase. J Immunol Methods (1983) 1.51
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature (1982) 1.45
Monoclonal antibody against human ovarian tumor-associated antigens. J Natl Cancer Inst (1986) 1.40
Detection of a human melanoma-associated antigen, p97, in histological sections of primary human melanomas. Int J Cancer (1982) 1.29
Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol (1981) 1.27
Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer (1985) 1.18
An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J Clin Pathol (1985) 1.12
Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst (1984) 1.11
Heterogeneous expression of melanoma-associated antigens in uveal melanomas. Curr Eye Res (1987) 1.06
Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. Am J Surg (1986) 1.04
Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method. J Nucl Med (1986) 1.04
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol (1986) 1.03
Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J Natl Cancer Inst (1981) 1.02
Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1. Cancer Res (1984) 0.99
Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Pathol (1985) 0.98
Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer (1984) 0.97
Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen. Cancer Res (1986) 0.91
Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. Cancer Res (1982) 0.87
Human T cell lines differing in phenotype and specificity are reactive with the same anti-idiotypic antibody. J Immunol (1986) 0.87
Biology of disease. Monoclonal antibodies and tumor-associated antigens. Lab Invest (1983) 0.87
Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers. J Clin Pathol (1986) 0.86
Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3. Cancer Immunol Immunother (1986) 0.83
Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma. Cancer Res (1986) 0.81
Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance. Cancer (1987) 0.80
Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells. Br J Cancer (1986) 0.79
Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues. Anticancer Res (1986) 0.79
New monoclonal antibodies against colon cancer-associated antigens. Cancer Res (1986) 0.78
Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes. Cancer (1987) 0.78
Distribution and organelle specificity of melanoma-associated antigens identified by Mo 465.12 in human malignant melanoma. Cancer (1985) 0.78
Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen. Mol Immunol (1987) 0.78
The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol (2001) 3.64
Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet (1996) 3.52
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001) 3.49
A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem (1987) 2.94
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol (1991) 2.88
Monoclonal antibody PAL-E specific for endothelium. Lab Invest (1985) 2.37
Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol (1997) 2.28
Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci U S A (1999) 2.17
Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (1984) 2.12
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J Cell Biol (2000) 2.00
Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol (1999) 2.00
Spermagglutinin formation in male rats by subcutaneously injected syngeneic epididymal spermatozoa and by vasoligation or vasectomy. J Reprod Fertil (1970) 1.96
Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer (1986) 1.95
Autoimmunity to sperm antigens in vasectomized men. Clin Exp Immunol (1975) 1.93
Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J Biol Chem (1995) 1.91
Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res (1986) 1.90
Matrix metalloproteinases in human melanoma. J Invest Dermatol (2000) 1.84
Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol (1996) 1.80
A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol (1986) 1.79
A Rab11-containing rapidly recycling compartment in macrophages that promotes phagocytosis. Proc Natl Acad Sci U S A (2000) 1.79
c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J Cell Sci (2001) 1.77
Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol (2001) 1.76
ARF6 is required for growth factor- and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. Mol Cell Biol (1999) 1.73
c-myc down-regulates class I HLA expression in human melanomas. EMBO J (1988) 1.72
Genetic transmission of viruses that incite mammary tumor in mice. Proc Natl Acad Sci U S A (1970) 1.71
Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis (1991) 1.68
The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance. J Biol Chem (1988) 1.66
Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol (1990) 1.66
Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest (1998) 1.65
Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer (1975) 1.65
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol (1996) 1.64
Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol (1991) 1.63
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians (1999) 1.62
N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol (1989) 1.61
Aneurysmal bone cysts: a clinicopathological study of 105 cases. Cancer (1977) 1.56
Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol (1997) 1.53
Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol (1990) 1.53
Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol (1993) 1.51
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest (1987) 1.48
Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol (1991) 1.47
Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer (1987) 1.41
Formation of hemidesmosomes in cells of a transformed murine mammary tumor cell line and mechanisms involved in adherence of these cells to laminin and kalinin. J Cell Sci (1993) 1.40
Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer (1997) 1.40
Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol (1995) 1.39
The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma. Neth J Surg (1990) 1.39
Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol (1994) 1.38
The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group. Ann Oncol (2001) 1.38
Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest (1996) 1.37
Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int (2001) 1.37
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer (1996) 1.37
Lymphangiogenesis in malignant tumours: Does it occur? J Pathol (2001) 1.37
Autospermagglutinins: immunofluorescent studies. Ann N Y Acad Sci (1965) 1.36
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol (1996) 1.36
Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest (1990) 1.36
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res (1997) 1.35
Reconstitution of a surface transferrin binding complex in insect form Trypanosoma brucei. EMBO J (1994) 1.34
Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids. J Cell Biol (1991) 1.34
The micro-sperm immobilization test: the use of only motile spermatozoa and studies of complement. Clin Exp Immunol (1978) 1.33
Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol (1995) 1.33
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Cytokeratin and neurofilament in lung carcinomas. Am J Pathol (1984) 1.29
Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer (1991) 1.28
Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res (1992) 1.28
Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol (2001) 1.26
Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol (2000) 1.24
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer (1999) 1.24
A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J (1995) 1.23
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer (1993) 1.23
Cre-loxP-mediated inactivation of the alpha6A integrin splice variant in vivo: evidence for a specific functional role of alpha6A in lymphocyte migration but not in heart development. J Cell Biol (1998) 1.23
Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res (2000) 1.22
Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene (2007) 1.22
Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescence. Clin Exp Immunol (1976) 1.21
Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol (1982) 1.21
Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer (2005) 1.21
Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest (1981) 1.20
Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood (1994) 1.20
A comparative study of the biologic and molecular basis of murine mammary carcinoma: a model for human breast cancer. J Natl Cancer Inst (1973) 1.19
Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur J Clin Invest (2000) 1.19
Molecular analysis of multifocal prostate cancer lesions. J Pathol (1999) 1.19
Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J (1993) 1.19
Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer (1985) 1.18
Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res (1997) 1.17
Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res (1988) 1.17
Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract. Histochemistry (1989) 1.17
Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg (1994) 1.16
Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. Am J Pathol (1984) 1.15
The origin of immunoglobulins in semen. Clin Exp Immunol (1974) 1.12
Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer (1985) 1.12
The antigens of human seminal plasma. With special reference to lactoferrin as a spermatozoa-coating antigen. Fertil Steril (1969) 1.12
TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett (1999) 1.10
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol (1991) 1.10
Auto-antigens of human spermatozoa. I. Solubilization of a new auto-antigen detected on swollen spermheads. Clin Exp Immunol (1974) 1.10